Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
The Journal of Biological Chemistry|June 25, 2003
The orphan nuclear receptor Rev-Erbalpha is a peroxisome proliferator-activated receptor (PPAR) gamma target gene and promotes PPARgamma-induced adipocyte differentiationCoralie Fontaine, Guillaume Dubois, Yannick Duguay, et al.
Biomacromolecules|June 8, 2021
Collagen Suprafibrillar Confinement Drives the Activity of Acidic Calcium-Binding Polymers on Apatite MineralizationJérémie Silvent, Marc Robin, Camila Bussola Tovani, et al.
Cancer Research|January 14, 2016
RASSF1A Suppresses the Invasion and Metastatic Potential of Human Non-Small Cell Lung Cancer Cells by Inhibiting YAP Activation through the GEF-H1/RhoB PathwayFatéméh Dubois, Maureen Keller, Olivier Calvayrac, et al.
Cancer Research|November 1, 2011
Egfl7 promotes tumor escape from immunity by repressing endothelial cell activationSuzanne Delfortrie, Sébastien Pinte, Virginie Mattot, et al.
Ebiomedicine|January 1, 2018
A Vascular Endothelial Growth Factor-Dependent Sprouting Angiogenesis Assay Based on an In Vitro Human Blood Vessel Model for the Study of Anti-Angiogenic DrugsJoris Pauty, Ryo Usuba, Irene Gayi Cheng, et al.
Plos One|June 19, 2009
A functional gammadeltaTCR/CD3 complex distinct from gammadeltaT cells is expressed by human eosinophilsFanny Legrand, Virginie Driss, Gaëtane Woerly, et al.
Differentiation; Research in Biological Diversity|July 7, 2021
Characterization of the proteome and metabolome of human liver sinusoidal endothelial-like cells derived from induced pluripotent stem cellsMathieu Danoy, Rachid Jellali, Yannick Tauran, et al.
Stem Cells (Dayton, Ohio)|February 15, 2012
Differential proteomic analysis of human glioblastoma and neural stem cells reveals HDGF as a novel angiogenic secreted factorCécile Thirant, Eva-Maria Galan-Moya, Luiz Gustavo Dubois, et al.
Stem Cell Reviews and Reports|October 6, 2017
Egfl7 Represses the Vasculogenic Potential of Human Endothelial Progenitor CellsClément d'Audigier, Sophie Susen, Adeline Blandinieres, et al.
Oncoimmunology|September 22, 2017
Co-delivery of the NKT agonist α-galactosylceramide and tumor antigens to cross-priming dendritic cells breaks tolerance to self-antigens and promotes antitumor responsesReem Ghinnagow, Julie De Meester, Luis Javier Cruz, et al.
Pageof 5